Navigation Links
New NACDS Chairman Larry Merlo Emphasizes Personal Commitment, Connection to Pharmacy
Date:4/27/2010

President of CVS/pharmacy emphasizes promotion of medication adherence and effectiveness during NACDS Annual Meeting

Palm Beach, FL (Vocus) April 27, 2010 -- In his first remarks as the newly elected chairman of the Board of the National Association of Chain Drug Stores (NACDS), Larry J. Merlo, president of CVS/pharmacy, paid tribute to the pharmacy icons who have advanced chain pharmacy and his own personal path. He also made clear his confidence that the personal link between pharmacists and patients can help improve patient health and healthcare delivery. Merlo delivered his comments today during the 2010 NACDS Annual Meeting.

Merlo described the beginning of his interest in pharmacy during high school; his pharmacy studies at the University of Pittsburgh and employment with Thrift Drug; his tenure with People’s Drug during which he first engaged with NACDS; and his resulting career with CVS/pharmacy. He acknowledged teachers, pharmacy managers and company leaders who fueled his passion for the industry.

He described some of the changes and trends shaping pharmacy, including electronic prescribing, the growth of the over-65 population, and aspects of the new healthcare reform law including the closing of the Medicare Part D “donut hole” and the expansion of the number of Americans with healthcare coverage.

Merlo also described ongoing healthcare reform challenges, including taming healthcare costs. Stating simply, and powerfully, “I think this is where we come into play,” Merlo launched into a declaration of pharmacy’s value and potential.

“As an industry, I believe we are positioned to help control the costs of healthcare by advocating for the value of what I’m going to call ‘Pharmacy Care,’” Merlo said. “Our strategy for ensuring the use of cost-effective medications is pretty clear; we need to promote adherence and effectiveness…In both areas, current research would suggest there are tremendous gaps.”

He described “adherence” as patients’ filling and taking the medications that providers have prescribed, and “effectiveness” as working with physicians to prescribe the correct medications. “We must define the value for community pharmacy in a reformed healthcare delivery system,” he said. “If you want to define the healthcare equation as access, cost and quality, I would offer that our industry, community pharmacy, is in the best position to effectively and positively contribute to all three pillars of that healthcare equation.”

Merlo showed a video of actual stories of pharmacists, who in the course of their practice have improved patients’ lives and even saved lives. He emphasized that similar stories play out daily in the pharmacies of diverse NACDS member companies, including regional and national traditional drug stores, supermarkets, mass merchants and club stores.

“There will be issues and challenges we will have to overcome, and through the NACDS agenda we will continue to work hard to navigate through the complexities the future brings. There is more that unites us than divides us: it’s the value our pharmacists bring to the healthcare equation as well as the role they play in their communities; and it’s the trust exhibited and the emotional connection that we saw and felt in the video. That story needs to continue to be told many times over. That’s what earns us a seat at the table,” Merlo concluded.

Merlo began his one-year term as NACDS chairman of the Board following his election on Monday, April 26.

Merlo's complete remarks are available here.

The National Association of Chain Drug Stores (NACDS) represents 154 traditional drug stores, supermarkets, and mass merchants with pharmacies – from regional chains with four stores to national companies. NACDS members also include more than 900 pharmacy and front-end suppliers, and over 70 international members from 24 countries. Chains operate 37,000 pharmacies, and employ more than 2.5 million employees, including 118,000 full-time pharmacists. They fill more than 2.5 billion prescriptions annually, which is more than 72 percent of annual prescriptions in the United States. The total economic impact of all retail stores with pharmacies transcends their $815 billion in annual sales. Every $1 spent in these stores creates a ripple effect of $3.82 in other industries, for a total economic impact of $3.11 trillion, equal to 26 percent of GDP. For more information about NACDS, visit www.NACDS.org.

Pharmacies. The face of neighborhood healthcare.

Contacts:
Stephen E. Schatz
NACDS
(703) 837-4196

Mike DeAngelis
CVS/pharmacy
(401) 770-2645

###

Read the full story at http://www.prweb.com/releases/Larry-Merlo/NACDS/prweb3925574.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. NACDS' Anderson Says Retailers and Suppliers' “Health and Wellness Renaissance” is Creating a “Historic, Watershed Moment”
2. NACDS Foundation Contributes $150,000 to Haiti Relief Efforts
3. NACDS RxIMPACT "Hill Day" Features More Advocates Increased Focus on Medication Adherence
4. Thomas J. Kent Jr. FDP Capital, LLC Chairman and Former NFL Player Jack Brewer Join Forces
5. DNC Chairman Tim Kaine Praises Historic Passage of Health Insurance Reform
6. Bausch + Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer
7. DNC Chairman Kaine Joins President Obama in Calling on Congress to Finish the Job, Pass Health Insurance Reform
8. DNC Chairman Tim Kaine Applauds President, Members of Congress on Todays Bipartisan Summit
9. JPMA Supports CPSC Chairman Tenenbaum's Continued Safety Efforts
10. Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports
11. U.S. Preventive Medicine Appoints Ron Loeppke, MD, MPH, as Vice Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New NACDS Chairman Larry Merlo Emphasizes Personal Commitment, Connection to Pharmacy
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: